Veracyte Executive Divests Stake Amid Diagnostic Expansion and Valuation Debate
Veracyte, Inc. (NASDAQ: VCYT) Executive Vice President and General Counsel Annie McGuire executed significant stock sales in early June 2026, totaling over $315,000 in value. These transactions, including both open market sales and tax-withholding dispositions, occurred as the company's stock traded near its 52-week high of $50.71. Concurrently, Ve…